Detection of brain metastasis with 68Ga-labeled PSMA ligand PET/CT: a novel radiotracer for imaging of prostate carcinoma.
Clin Nucl Med
; 40(4): 328-9, 2015 Apr.
Article
em En
| MEDLINE
| ID: mdl-25674861
ABSTRACT
Brain metastasis in prostate cancer is rare and not expected at initial presentation especially when the patient is asymptomatic for the same. A 45-year-old male patient undergoing initial evaluation for newly diagnosed prostatic adenocarcinoma was referred to our department for 99mTc-MDP bone scintigraphy. As part of the study protocol, he also underwent Glu-NH-CO-NH-Lys-(Ahx)-[Ga-68(HBED-CC)] (68Ga-PSMA) PET/CT, which revealed tracer accumulation in brain lesions, apart from localization in the primary, lymph node, and bone metastases. A subsequent MR evaluation confirmed brain metastases.
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Oligopeptídeos
/
Neoplasias da Próstata
/
Neoplasias Encefálicas
/
Adenocarcinoma
/
Ácido Edético
/
Compostos Radiofarmacêuticos
Idioma:
En
Ano de publicação:
2015
Tipo de documento:
Article